Ana Marija Slišković, Jozefina Palić, Tamara Božina, Lana Ganoci, Majda Vrkić Kirhmajer, Vladimir Trkulja, Joško Bulum, Livija Šimičević
Original articles, Volume 34, June, Issue 2
KEYWORDS: adverse drug reactions; cardiovascular disease; hemorrhage; pharmacogenetics; risk factors; rivaroxaban